Frontiers in Immunology | Vaccines and Molecular Therapeutics

Original Research

Published on 10 May 2024

Immunoinformatics assisted profiling of West Nile virus proteome to determine immunodominant epitopes for the development of next-generation multi-peptide vaccine

in Vaccines and Molecular Therapeutics

Alaa Karkashan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1395870

2,938 views
3 citations

Original Research

Published on 10 May 2024

A TLR4 ligand-based adjuvant for promoting the immunogenicity of typhoid subunit vaccines

in Vaccines and Molecular Therapeutics

Kishore R. Alugupalli

Frontiers in Immunology

doi 10.3389/fimmu.2024.1383476

1,568 views
2 citations

Original Research

Published on 10 May 2024

Low-dose M.tb infection but not BCG or MTBVAC vaccination enhances heterologous antibody titres in non-human primates

in Vaccines and Molecular Therapeutics

Marco Polo Peralta Alvarez
Holly Jones
Hugo Redondo Azema
Chloe Davis
Andrew D. White
Charlotte Sarfas
Mike Dennis
Shuailin Li
Daniel Wright
Eugenia Puentes

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387454

2,860 views
4 citations

Original Research

Published on 08 May 2024

The single-dose Janssen Ad26.COV2.S COVID-19 vaccine elicited robust and persistent anti-spike IgG antibody responses in a 12-month Ugandan cohort

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
Laban Kato
Gerald Kevin Oluka
Violet Ankunda
Jackson Sembera
Claire Baine
Isaac Kitabye
Angela Namuyanja
Solomon Opio
Joseph Ssebwana Katende

Frontiers in Immunology

doi 10.3389/fimmu.2024.1384668

1,732 views

Original Research

Published on 08 May 2024

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities

in Vaccines and Molecular Therapeutics

Jéromine Klingler
Shreyas Kowdle
Juan C. Bandres
Rozita Emami-Gorizi
Raymond A. Alvarez
Priyanka G. Rao
Fatima Amanat
Charles Gleason
Giulio Kleiner
Viviana Simon

Frontiers in Immunology

doi 10.3389/fimmu.2024.1382619

2,301 views
3 citations

Original Research

Published on 08 May 2024

BacScan: a novel genome-wide strategy for uncovering broadly immunogenic proteins in bacteria

in Vaccines and Molecular Therapeutics

Junhua Dong
Qian Zhang
Jinyue Yang
Yacan Zhao
Zhuangxia Miao
Siyang Pei
Huan Qin
Changwei Jing
Guoyuan Wen
Anding Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392456

2,765 views

Original Research

Published on 07 May 2024

Distinct T cell responsiveness to different COVID-19 vaccines and cross-reactivity to SARS-CoV-2 variants with age and CMV status

in Vaccines and Molecular Therapeutics

Jolanda Brummelman
Sara Suárez-Hernández
Lia de Rond
Marjan Bogaard-van Maurik
Petra Molenaar
Emma van Wijlen
Debbie Oomen
Lisa Beckers
Nynke Y. Rots
Josine van Beek

Frontiers in Immunology

doi 10.3389/fimmu.2024.1392477

2,764 views
1 citation

Original Research

Published on 02 May 2024

Long-term humoral and cellular immunity against vaccine strains and Omicron subvariants (BQ.1.1, BN.1, XBB.1, and EG.5) after bivalent COVID-19 vaccination

in Vaccines and Molecular Therapeutics

Hakjun Hyun
Eliel Nham
Hye Seong
Jin Gu Yoon
Ji Yun Noh
Hee Jin Cheong
Woo Joo Kim
Sun Kyung Yoon
Se-Jin Park
WonSeok Gwak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1385135

2,403 views
4 citations

Perspective

Published on 02 May 2024

Protecting the vulnerable: addressing the COVID-19 care needs of people with compromised immunity

in Vaccines and Molecular Therapeutics

Raymund R. Razonable

Frontiers in Immunology

doi 10.3389/fimmu.2024.1397040

4,174 views
6 citations

Original Research

Published on 01 May 2024

Antibodies to Aedes aegypti D7L salivary proteins as a new serological tool to estimate human exposure to Aedes mosquitoes

in Vaccines and Molecular Therapeutics

Sophana Chea
Laura Willen
Sreynik Nhek
Piseth Ly
Kristina Tang
James Oristian
Roberto Salas-Carrillo
Aiyana Ponce
Paola Carolina Valenzuela Leon
Dara Kong

Frontiers in Immunology

doi 10.3389/fimmu.2024.1368066

4,242 views
3 citations

Original Research

Published on 30 Apr 2024

A universal recombinant adenovirus type 5 vector-based COVID-19 vaccine

in Vaccines and Molecular Therapeutics

Xingxing Li
Qinhua Peng
Xinyu Liu
Hongshan Xu
Jingjing Liu
Xiaohong Wu
Qiang Ye
Min Li
Yuhua Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1374486

2,581 views
1 citation

Original Research

Published on 30 Apr 2024

A two-dose viral-vectored Plasmodium vivax multistage vaccine confers durable protection and transmission-blockade in a pre-clinical study

in Vaccines and Molecular Therapeutics

Yutaro Yamamoto
Camila Fabbri
Daiki Okuhara
Rina Takagi
Yuna Kawabata
Takuto Katayama
Mitsuhiro Iyori
Ammar A. Hasyim
Akihiko Sakamoto
Hiroaki Mizukami

Frontiers in Immunology

doi 10.3389/fimmu.2024.1372584

2,598 views
1 citation

Original Research

Published on 30 Apr 2024

Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B

in Vaccines and Molecular Therapeutics

Yujia Jiang
Rong Wang
Jiazheng Guo
Kexuan Cheng
Lei Chen
Xi Wang
Yating Li
Peng Du
Chen Gao
Jiansheng Lu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380694

2,022 views
2 citations

Original Research

Published on 29 Apr 2024

Saccharomyces cerevisiae oral immunization in mice using multi-antigen of the African swine fever virus elicits a robust immune response

in Vaccines and Molecular Therapeutics

Shuo Gao
Wenfeng Zuo
Chao Kang
Zhong Zou
Kaiqi Zhang
Jun Qiu
Xiaomin Shang
Jingjing Li
Yuanfeng Zhang
Qi Zuo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1373656

8,393 views
3 citations

Original Research

Published on 24 Apr 2024

A conserved motif in the immune-subdominant RAP-1 related antigen of Babesia bovis contains a B-cell epitope recognized by antibodies from protected cattle

in Vaccines and Molecular Therapeutics

Manuel J. Rojas
Reginaldo G. Bastos
Jinna Navas
Jacob M. Laughery
Paul A. Lacy
Carlos E. Suarez

Frontiers in Immunology

doi 10.3389/fimmu.2024.1380660

2,346 views
2 citations

Methods

Published on 24 Apr 2024

Refined analytical pipeline for the pharmacodynamic assessment of T-cell responses to vaccine antigens

in Vaccines and Molecular Therapeutics

Michail Angelos Pavlidis
Nadia Viborg
Mads Lausen
Birgitte Rønø
Daniela Kleine-Kohlbrecher

Frontiers in Immunology

doi 10.3389/fimmu.2024.1404121

2,397 views